War Torn LabZ SARMS MK-677 Ibutamoren 60 Capsules

  • £45.00


Looking for a potent Human Growth Hormone release that doesn’t involve needles? Ibutamoren (mk-677 Treatment group) may just fit the bill…

 

  • Increases IGF-1 Levels Concentration  and growth hormone serum levels
  • Promotes lean muscle mass gain
  • Increases fat oxidation
  • Boosts recovery and healing including bones, tendons, and ligaments
  • Tightens the skin
  • Improves Quality of Sleep
  • Great for anyone Human Growth Hormone Deficiency

 

In addition to increases in muscle tissue and a leaner physique, studies suggest that Ibutamoren can produce significant anti-ageing effects, as well as improved bone density and more rapid recovery times.

A single tablet taken daily is designed to release wave after wave of naturally secreted human growth hormone from the pituitary gland. Perfect for GH-Deficient adults.

BENEFITS OF MK-677 treatment Ibutamoren oral administration

Muscle retention: MK-677 Ibutamoren has been shown to reverse protein loss and associated muscle wasting - good news for bodybuilders who want to diet to lose fat but hate the idea of sacrificing hard-earned muscle mass. Lean Muscle mass  made with HGH is longer-lasting, so any gains you make on Ibutamoren are likely to last longer, too.
Lean Muscle Mass :  MK-677 Ibutamoren doesn’t just help you hang on to muscle mass in the face of a possibly catabolic environment. It can also boost the growth of new muscle cells. It does this by stimulating secretion of GH and Igf-i = insulin-like growth factor Concentration in the pituitary gland which increase protein synthesis. That means hefty gains if you’re already eating and training right. Using MK-677 Ibutamoren will increase in appetite.
Bone strength: All that extra growth hormone and igf-i = insulin-like growth factor igf-1 levels will mean better bone density in the short term and the long term, which is good news for your gains now, and for your health once you get older. Look better and stay more active in later life? MK-677 treatment  Ibutamoren Yes please.
Sleep and recovery: Mk-677 Ibutamoren may improve the amount of REM sleep you get (and the quality of your sleep), which means better recovery between training and more time in that muscle-gaining anabolic state. Better sleep also means more energy for training the next day, plus less hunger and fewer cravings.
Nootropics: mk-677 Ibutamoren is also popular with the nootropic crowd because it is thought to have brain benefits. This means better well being and mood, with more motivation and focus on training and cardio.
Fat loss: Using MK-677 Ibutamoren may encourage your body to use stored fat for energy, and remember that it protects muscle at the same time due to higher igf-1 levels.. This means true lean gains: fat loss with muscle gain for that full, pumped, shredded look. You will get an Increase in Appetite so make sure you get rid of all the junk food out the house.

 

Oral administration of the MK-677 treatment Group has been used on elderly subjects with oral administration in an MK-677 treatment to heal broken bones more efficiently, increasing their Bone Mineral Density.

HOW DOES MK-677 GROUP WORK?

MK-677 Ibutamoren is a Growth Hormone Secretagogue  which once ingested tricks the pituitary gland into working overdrive. The massive boost in GH or human growth hormone and gf-i = insulin-like growth factor Concentration is what makes it so interesting to the bodybuilding world.  This is a perfect product for GH-Deficient adults This Active Growth Hormone Combined with the appropriate diet and exercise regimen, an introduction of Ibutamoren can cause impressive muscle growth alongside much improved fat loss. Just be aware that as well as Lean Muscle Mass Gains you will have an Increase in appetite initially. MK-677 also mimics hormone Ghrelin which is a hunger hormone so you should have a healthy appetite but ironically also good for weight loss.

SIDE EFFECTS/Adverse effects of MK-677 Ibutamoren 

The most common side-effects experienced with Ibutamoren include slight lethargy, some experience increased appetite, although this isn’t always a negative side-effect for those who need some help gaining weight/bulking.

Although rare, some users have reported headaches and nausea, which would appear to increase in prominence at higher doses.

Oral administration of MK-677 group IS SAFE FOR WOMEN

MK-677 Ibutamoren is fine to use for both men and women as it doesn’t affect the amount of testosterone or estrogen the body produces. This means that there is zero-risk of specific hormonal imbalances and unwanted side-effects like puffy nipples, heightened aggression or hair loss. Many women suffer with low Bone Mineral Density so this could potentially help them for this also. Also excellent for GH-Deficient adults.

HOW TO USE THE MK-677 GROUP & DOSAGE

Most users will tend to use MK-677 (25 Mg per daily administration although MK-677 is still very effective at daily administration doses as low as 10mg, which can be useful for people who feel tired or hungry at higher doses. Start at 10mg for the first week to assess how you feel if it’s your first time using the compound.

Ibutamoren mk-677 can be taken by itself or as part of a stack with other compounds. It has a long half-life of 24 hours which means you can take your daily dose in one go - but it does spike growth hormone, so you might like to split your dose to avoid tiredness after the GH spike.

The benefits and efficacy of MK-677 increases with long term use, so the recommended cycle length is 3-6 months for optimum results no more than a daily administration dose of MK-677 (25 Mg

STACKING MK-677

MK-677 is often stacked with Cardarine, LGD-033 and RAD-140 both selective androgen receptor modulators, but it is an exceptionally versatile compound and can be stacked with anything else.

Stacking Ibutamoren with Cardarine (another compound commonly mistaken for a SARM), or Ligandrol, will increase lean mass and decrease body fat. Stacking it with Testolone RAD-140 is a winning combination for rapid muscle mass gain and fat loss.

But with an orally active version like Ibutamoren, a single dose can show a sustained increase benefits throughout the entire day.And the results from the studies I’ve seen, show promising results.

Is a PCT (Post Cycle Therapy) necessary after taking MK-677?

No a PCT isn't required after a course of MK-677.

SARMS (selective androgen receptor modulators) ARE FOR RESEARCH PURPOSES ONLY. THIS PRODUCT IS NOT A NUTRITIONAL SUPPLEMENT, NOR A FOOD AND SHOULD NOT BE USED AS ONE. THIS PRODUCT IS SOLELY FOR RESEARCH PURPOSES ONLY

 

Technical studies

 

Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults.

 

These effects of physiologically stimulated GH secretion contrast with those of GH administered by injection: edema; arthralgia; carpal tunnel syndrome; gynecomastia; and new onset of impaired fasting glucose and diabetes mellitus in some subjects (8).Both GH and MK-677 increase insulin resistance and blood glucose in the elderly

 

Effects of treatment an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized, Controlled Trial - PMC

Fat-Free Mass, Total Appendicular Skeletal Muscle Mass (TASM) (FIGURE 3A) and Thigh Muscle Area (APPENDIX TABLE 2) APPENDIX TABLE 2 EFFECTS OF TREATMENT ON BODY COMPOSITION BASELINE6 MONTHS 12 MONTHS BODY COMPOSITION Mean (SD)minimum-maximum Mean Change 95% CIP Value MK-677 vs.

 

Blinded supplies of MK-677 and placebo tablets were provided by Merck Research Laboratories, Inc., stored by a research pharmacist, and were dispensed in a blinded manner according to a randomization table with stratification for gender and hormone replacement therapy.

Similarly, linear contrasts were constructed to estimate the baseline-adjusted difference in changes in the response at 6 and 12 months between the MK-677 and placebo groups.

Similarly, linear contrasts were constructed to estimate the baseline-adjusted difference in changes in the response at 6 and 12 months between the MK-677 and placebo groups.

MK-677 and placebo were kindly provided by Merck & Co., Inc.We acknowledge the contributions of Mark L.

 

Oral Administration of the Growth Hormone Secretagogue MK‐677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults - Murphy - 1999 - Journal of Bone and Mineral Research - Wiley Online Library

We determined the effect of chronic administration of the GH secretagogue, MK-677, on serum IGF-I and markers of bone turnover in 187 elderly adults (65 years or older) enrolled in three randomized, double-blind, placebo-controlled clinical studies lasting 2–9 weeks.

Failure to observe an increase in serum BSAP probably reflects the very short duration of the trial and perhaps a slower response since rhGH has had a variable influence on serum BSAP in clinical studies. 25 The third study afforded the opportunity to examine the longer term influence of MK-677 on the biochemical markers of bone turnover in the frail elderly.

 

MK-677 (25 mg) was generally well tolerated and without clinically significant adverse experiences.

 

Surprisingly, thigh muscle cross-sectional area did not increase, although the study is not powered to detect small but potentially important differences with the imprecise single slice CT method that we used.

Changes in bone mineral density consistent with increased bone remodeling occurred in MK-677-treated subjects.

 

Scientists do have hope though that a couple of noticeable indirect methods may explain how MK 677 can be of assistance to cognitive function.

Obtaining the proper amount of sleep each night is extremely important when trying to achieve adequate cognitive function.

MK-677 can improve cognitive function by assisting individuals with the ability to get a good night's rest.

The ability of MK-677 to stimulate IGF-1 production can also indirectly improve cognitive function based on IGF-1's role in cognitive function.

We know that sleep is essential for good cognitive function.

Insulin-like growth factor-I and cognitive function in healthy older men.

In this study, a ghrelin mimetic transiently increased appetite, a novel effect that might counteract physiological anorexia, which is one cause of weight loss in the elderly, Ghrelin increases fat stores, unlike GH which is lipolytic.

 

One month after crossover, and at 3 and 6 months after study completion, IGF-I concentrations returned to pretreatment levels.DISCUSSIONHealthy elderly individuals who took the ghrelin mimetic MK-677 experienced a sustained increase in the amplitude of pulsatile GH secretion and IGF-I to levels seen in young adults.

 

IBUTALEAN is a 100% natural alternative to the well-known SARM Ibutamoren, a product of the company Brutal Force preparing natural strengthening supplements for bodybuilding and weightlifting.

IBUTALEAN is a 100% natural alternative to the well-known SARM Ibutamoren, a product of the company Brutal Force preparing natural strengthening supplements for bodybuilding and weightlifting.

Frailty is one of the scourges of the oldest old, and as researchers are beginning to learn about its causes, they are asking if growth hormone deficiency is one cause.

The likely mechanism was activation of the ghrelin receptor by MK-677, with feedback by IGF-I preventing excess GH production.

Ibutamoren increases growth hormone levels by mimicking the action of the hormone ghrelin and binding to one of the ghrelin receptors (GHSR) in the brain.

Reported side effects of MK-677 are typically the result of unnaturally high levels of growth hormone in the body from taking too much too often, which include: Increased appetite Lethargy Joint pain if you have previous medical conditions or elevated hormone levels Insulin resistance Possible increase in prolactin levels, which can be controlled When dosed properly, the side effects of MK-677 are minimal to none compared to the results you get from taking it properly.

 

Changes in bone mineral density consistent with increased bone remodeling occurred in MK-677-treated subjects.

Femoral neck BMD declined at 12 months with MK-677, which is consistent with increased bone remodeling, as occurs with GH.

GH reduces abdominal visceral fat (AVF) in GH-deficient adults

Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women:

GH reduces abdominal visceral fat (AVF) in GH-deficient adults and abdominally obese, postmenopausal women, but not normal elderly subjects

The reversal of diet-induced negative nitrogen balance by GH suggests a possible therapeutic role for GH treatment in catabolic patients.

These anabolic properties suggest that it may be useful in the treatment of catabolic patients, particularly catabolism induced or worsened in severity by inadequate caloric intake.

Sixty-five healthy men and women (on or off hormone replacement therapy) ages 60-81.

A two-year, randomized, double-blind, modified-crossover trial of once-daily oral administration of 25 mg MK-677 or placebo (2:1 ratio) to healthy older adults (men, women on and women off hormone replacement therapy) was performed.

In each of three subgroups of subjects (men, women off and women on hormone replacement therapy), 16 subjects will receive MK-677 and 8 will receive placebo.

These effects of physiologically stimulated GH secretion contrast with those of GH administered by injection: edema; arthralgia; carpal tunnel syndrome; gynecomastia; and new onset of impaired fasting glucose and diabetes mellitus in some subjects. Both GH and MK-677 increase insulin resistance and blood glucose in the elderly.

 

One month after crossover, and at 3 and 6 months after study completion, IGF-I concentrations returned to pretreatment levels.DISCUSSIONHealthy elderly individuals who took the ghrelin mimetic MK-677 experienced a sustained increase in the amplitude of pulsatile GH secretion and IGF-I to levels seen in young adults.

Mean IGF-I concentration increased significantly during MK-677 to 264 ± 31 ng/mL (mean for the last 5 days of treatment) compared with 188 ± 19 ng/mL with placebo (P < 0.01).